Delivery Order SPE2DE24D0013-SPE2D625F3JGP
- Not listed
- The U.S. Defense Medical Supply Chain awarded a $13.6K delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on September 2, 2025, with completion targeted for September 9, 2025. This firm fixed-price delivery order (Contract No. 4569302261) procures diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and represents a continuation of...
- This delivery order, awarded to Cepheid Inc. on September 11, 2025, represents a firm fixed-price contract valued at $1,155 with a completion date of September 18, 2025. The award was issued by the Medical Supply Chain division within the Department of Defense and will be performed at Cepheid's facility in Sunnyvale, California. No small business set-aside designation was applied to this contract. Cepheid, a leading manufacturer of molecular diagnostic solutions, specializes in GeneXpert...
- The Defense Department's Medical Supply Chain awarded a $16.2K delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 27, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a continuation of the Department's procurement of diagnostic testing capabilities through Cepheid's established federal contracting vehicles. Cepheid specializes in...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $2,471.70 by the Defense Department's Medical Supply Chain organization on July 18, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order carries no set-aside designation and represents procurement of diagnostic equipment, reagents, or testing services from Cepheid's core product portfolio, which includes GeneXpert...
- The U.S. Defense Department's Medical Supply Chain organization awarded a delivery order valued at $9,319 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 1, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The delivery order is issued under one of Cepheid's existing Indefinite Delivery Vehicle...
- This delivery order, issued on July 28, 2025, awards Cepheid Inc. a firm fixed-price contract valued at $1,190.28 for molecular diagnostic solutions under a Defense Logistics Agency Medical Supply Chain program. The contract is set to be completed by August 11, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. The award reflects the company's established role as a key supplier of diagnostic systems and reagents to federal defense and healthcare agencies,...
- The Defense Logistics Agency has awarded a $13.6K delivery order (XPRS4PLEX-10) to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, awarded on September 11, 2025, with an ultimate completion date of September 18, 2025, represents a continuation of the federal government's procurement of Cepheid's diagnostic testing capabilities. The award carries no set-aside designation and will be performed at Cepheid's...
- The U.S. Defense Department's Medical Supply Chain division awarded a $19,375 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, with an ultimate completion date of September 15, 2025. This delivery order (XPRS4PLEX-10) represents a continuation of the federal government's ongoing procurement of molecular diagnostic solutions from the Sunnyvale, California-based manufacturer. The award carries no set-aside designation and is likely issued under one of Cepheid's existing...
- This delivery order, awarded on September 9, 2025, represents a $41,490 firm fixed-price contract between the Defense Logistics Agency (Medical Supply Chain) and Cepheid Inc. for molecular diagnostic solutions. The contract, which runs through September 16, 2025, procures diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic systems, specializes in advanced infectious...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $6,390 on September 9, 2025, by the Defense Department's Medical Supply Chain office. The delivery order, designated XPRS4PLEX-10, has an ultimate completion date of September 16, 2025, and involves performance at Cepheid's Sunnyvale facility. This award carries no set-aside designation and represents a discrete procurement action under the company's...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F3JGPDelivery Order
This delivery order, issued on September 12, 2025, awards $34,680 to Cepheid Inc. under a firm fixed-price contract with no set-aside designation. The award, which is set to conclude by September 19, 2025, represents a short-duration delivery order for molecular diagnostic solutions to be performed at the contractor's facility in Sunnyvale, California. Cepheid is a leading manufacturer of molecular diagnostic systems and testing solutions, specializing in point-of-care detection technologies for infectious diseases including COVID-19, influenza, RSV, and other clinical conditions. The funding agency is the Defense Supply Chain entity operating under the Department of Defense. This delivery order likely leverages one of Cepheid's existing Indefinite Delivery Vehicle contracts, which provide the framework for ongoing procurement of diagnostic reagents, assays, and testing services. Cepheid maintains substantial IDV agreements with the Department of Veterans Affairs, including a $32.8 million contract with VA's Veterans Integrated Service Network 6 extending through September 2030 for molecular diagnostic testing system reagents and assays. The company's federal footprint spans multiple defense and civilian healthcare agencies, positioning it as a critical supplier of diagnostic capabilities across the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.7k | 9/12/25 |